portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Controllers Up Stakes In Fosun Pharma, Hongbaoli
 
CreateTime:2012-02-24     Source:capitalvue.com Editor:puchangping
Text Size:       
 

Nanjing Hongbaoli Corporation (002165) and Shanghai Fosun Pharmaceutical (Group) (600196) announced share buy backs by major shareholders, reports Shanghai Securities News, citing a company filing.

Jiangsu Baoyuan Investment, the largest shareholder of Hongbaoli, purchased 527,000 shares, or a 0.19 percent stake, at an average price of 11.24 yuan per share as it is optimistic about the future development prospects of the listed company.

Fosun Pharma said Fosun Group purchased 824,000 shares, or a 0.04 percent interest, yesterday. This brings the total shareholding of Fosun Group to 48.1 percent.

Fosun Group plans to up its stake by up to two percent within the next one year.


 


Related Reports
China Pharmaceutical Glass Packaging Industry Report, 2014-2017
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1